First sales data fires up shares in Mesoblast Group
MELBOURNE: Biotech Mesoblast has reported strong initial sales of its cell therapy, Ryoncil, its first
MELBOURNE: Biotech Mesoblast has reported strong initial sales of its cell therapy, Ryoncil, its first